Business
PARADIGM RECEIVES $2.32m R&D TAX INCENTIVE REFUND
PARADIGM RECEIVES $2.32m R&D TAX INCENTIVE REFUND
About this update from Paradigm Biopharmaceuticals Ltd.
[{"type":"text","content":"Paradigm Biopharmaceuticals Ltd has released a press release. View Attachment","length":263,"tagName":"div"}]